Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15466
Abstract: Gastrointestinal (GI) bleeding is the most frequent single site of oral anticoagulant (OAC)‐associated major bleeding. Patients with major GI bleeding experience morbidity and a substantial risk of short‐term all‐cause mortality up to 10%. While OACs… read more here.
Keywords: risk; framework; gastrointestinal bleeding; anticoagulant associated ... See more keywords
In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14081937
Abstract: Simple Summary Patients with venous thromboembolism events in the context of cancer should receive anticoagulants as long as the cancer is active. Therefore, a tailor-made anticoagulation strategy should rely on an individualized assessment of the… read more here.
Keywords: associated bleeding; assessment; cancer; risk ... See more keywords